Radiodermatitis Market

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $4,500	160 Pages	Coherent Market Insights	July, 2023	CMI18107873

Best Price Guarantee
Price	from $4,500
Length	160 Pages
Publisher	Coherent Market Insights
Published Date	July, 2023
SKU	CMI18107873

Radiodermatitis Market, By Product Type (Topical Agents( Corticosteroids, Hydrophilic Creams, Others), Oral Medication( Corticosteroids, Other, Analgesic & Anti-Inflammatory) Dressings ( Hydrogel, Hydrocolloid, No Sting Barrier Film, Honey Impregnated Dressing, Silicone coated Dressing, Others ), By Distribution channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

Radiodermatitis (radiation dermatitis, radiation-related skin reactions, or radiation damage) is a serious side effect of ionizing radiation during cancer therapy and nuclear attacks and disasters such as Fukushima in 2011. Specifically, 95% of cancer patients receiving radiation therapy develop some form of radiation dermatitis, including erythema. , dry scale and moist scale. These skin reactions to radiation lead to countless complications, such as treatment delays, reduced aesthetic appeal, and reduced quality of life. Recent technological advances and new treatment regimens have only partially succeeded in alleviating these harmful side effects. The most common cause of radiation dermatitis is radiation therapy, which is used to treat cancer and other disorders. Disasters and nuclear assaults may also contribute to the condition. Retail pharmacies and online pharmacies are included in the distribution route.

Market Dynamics

Radiation dermatitis, also known as X-ray rash, radiation dermatitis, radiation skin reactions or radiation damage, is a side effect of external ionizing radiation. Radiation therapy, used to treat cancer or other diseases, is a leading cause of radiation dermatitis. Nuclear attacks and disasters can also cause the condition. For instance, on May 14, 2020, an article published by National Center for Biotechnology Information (NCBI) explained none of the recommended products for patients are based on evidence-based practice, and the effectiveness of these products in preventing or treating radiation dermatitis is not reliable. It has previously been suggested that moist skin care with urea cream is effective in reducing the severity of acute skin reactions. In addition, recent reports have recommended the use of steroids, calendula, Hypericum perforatum, and neem oil for the treatment of acute radiodermatitis.

Key features of the study:

This report provides an in-depth analysis of the global radiodermatitis market and provides market size (US$ Mn) and compound annual growth rate (CAGR) for the forecast period (2023–2030), considering 2022 as the base year.
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global radiodermatitis market based on the following parameters– company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Acelity, Inc. (3M), BMG Pharma S.r.l., ConvaTec Group PLC, DermaSciences Inc. (Integra LifeSciences Holdings Corporation), Intermed Pharmaceuticals, Mölnlycke Health Care, Smith & Nephew Plc, Stratpharma AG, Kannalife, Inc., McKesson Corporation.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global radiodermatitis market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global radiodermatitis market.

Detailed Segmentation:

Global Radiodermatitis Market, By Product Type:
Topical Agents
Corticosteroids
Hydrophilic Creams
Others
Oral Medication
Corticosteroids
Other
Analgesic & Anti-Inflammatory
Dressing
Hydrogel, Hydrocolloid
No Sting Barrier Film
Honey Impregnated Dressing
Silicone coated Dressing
Others
Global Radiodermatitis Market, By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Radiodermatitis Market, By Region:
NorthAmerica
U.S.
Canada
LatinAmerica
Brazil
Mexico
Argentina
Rest of Latin America
Europe
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
AsiaPacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
MiddleEast
GCC
Israel
Rest of Middle East
Africa
South Africa
Central Africa
North Africa
Company Profiles
Acelity, Inc. (3M)
BMG Pharma S.r.l.
ConvaTec Group PLC
DermaSciences Inc. (Integra LifeSciences Holdings Corporation)
Intermed Pharmaceuticals
Mölnlycke Health Care
Smith & Nephew Plc.
Stratpharma AG
Kannalife, Inc.
McKesson Corporation

1. Research Objectives and Assumptions: Research Objectives; Assumptions; Abbreviations
2. Market Purview: Report Description; Market Definition and Scope; Executive Summary; Market Snapshot, By Product Type; Market Snapshot, By Distribution Channel; Market Snapshot, By Region; Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis: Market Dynamics; Drivers; Restraints; Market Opportunities; Impact Analysis; Recent Product Launches; Epidemiology; Merger, Acquisition, and Collaboration; Regulatory Scenario; Key Developments; PEST Analysis
4. Global Radiodermatitis Market– COVID-19 Impact Analysis: Economic Impact; COVID-19 Epidemiology; Impact on Supply and Demand
5. Global Radiodermatitis Market, By Product Type, 2018–2030, (US$ Million): Introduction; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2018–2030; Segment Trends; Topical Agents; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Million); Corticosteroids; Hydrophilic Creams; Others; Oral Medication; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Million); Corticosteroids; Other; Analgesic & Anti-Inflammatory; Dressings; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Million); Hydrogel; Hydrocolloid; No Sting Barrier Film; Honey Impregnated Dressing; Silicone coated Dressing; Others
6. Global Radiodermatitis Market, By Distribution Channel, 2018–2030, (US$ Million): Introduction; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2018–2030; Segment Trends; Hospital Pharmacies; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Million); Retail Pharmacies; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Million); Online Pharmacies; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Million)
7. Global Radiodermatitis Market, By Region, 2018–2030, (US$ Million): Introduction; Market Share Analysis, By Region, 2023 and 2030 (%); Y-o-Y Growth Analysis, For Region, 2018–2030; Regional Trends; North America; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Product type, 2018 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Country, 2018–2030, (US$ Million); U.S.; Canada; Latin America; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Product type, 2018-2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Country, 2018–2030, (US$ Million); Brazil; Mexico; Argentina; Rest of Latin America; Europe; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Product type, 2018-2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Country, 2018–2030, (US$ Million); U.K.; Germany; Italy; France; Spain; Russia; Rest of Europe; Asia Pacific; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Product type, 2018-2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Country, 2018–2030, (US$ Million); China; India; Japan; ASEAN; Australia; South Korea; Rest of Asia Pacific; Middle East; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Product type, 2018-2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Country, 2018–2030, (US$ Million); GCC; Israel; Rest of Middle East; Africa; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Product type, 2018-2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2018–2030, (US$ Million); North Africa; Central Africa; South Africa
8. Competitive Landscape: Acelity, Inc. (3M); Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; BMG Pharma S.r.l.; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; ConvaTec Group PLC; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; DermaSciences Inc. (Integra LifeSciences Holdings Corporation); Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; Intermed Pharmaceuticals; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; Mölnlycke Health Care; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; Smith & Nephew Plc; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; Stratpharma AG; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; Kannalife, Inc.; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; McKesson Corporation; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies
9. Section: Research Methodology; About Us; *Browse 25 market data tables and 29 figures on “Global Radiodermatitis Market” - Global forecast to 2030